RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

DCVC Opportunity Fund II GP, LLC's Holding History (CIK: 0001668343)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 3,951,141 Value ($000) $16,160 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 3,951,141 Value ($000) $19,282 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 3,951,141 Value ($000) $19,993 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 3,951,141 Value ($000) $20,902 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 3,951,141 Value ($000) $26,710 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 3,951,141 Value ($000) $26,038 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 3,951,141 Value ($000) $29,634 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 3,951,141 Value ($000) $39,393 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 3,951,141 Value ($000) $38,958 Avg Close $7.13 Range $4.97 - $11.17
Q3 2022
Shares 3,951,141 Value ($000) $42,040 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 3,951,141 Value ($000) $32,162 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 3,951,141 Value ($000) $28,290 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 3,951,141 Value ($000) $67,683 Avg Close $18.82 Range $15.25 - $23.86